Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Tobias A. W. Holderried"'
Autor:
Tobias A. W. Holderried, Isabel Stasik, Marie-Therese Schmitz, Friederike Schmitz, Tizian K. Meyer, Leonie Stauß, Martin Kirschner, Dirk Skowasch, Jennifer Landsberg, Matthias Schmid, Peter Brossart, Martin Holderried
Publikováno v:
Frontiers in Digital Health, Vol 6 (2024)
BackgroundThe use of online information and communication is globally increasing in the healthcare sector. In addition to known benefits in other medical fields, possible specific potentials of eHealth lie in the monitoring of oncological patients un
Externí odkaz:
https://doaj.org/article/ccf7c0d1acbd47ca81502d25c80d7257
Autor:
Claudio Neidhöfer, Esther Sib, Marcel Neuenhoff, Oliver Schwengers, Tobias Dummin, Christian Buechler, Niklas Klein, Julian Balks, Katharina Axtmann, Katjana Schwab, Tobias A. W. Holderried, Georg Feldmann, Peter Brossart, Steffen Engelhart, Nico T. Mutters, Gabriele Bierbaum, Marijo Parčina
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 12, Iss 1, Pp 1-17 (2023)
Abstract Background Hospitals with their high antimicrobial selection pressure represent the presumably most important reservoir of multidrug-resistant human pathogens. Antibiotics administered in the course of treatment are excreted and discharged i
Externí odkaz:
https://doaj.org/article/f55e9aef5f514f97ad547deec3ed7ce5
Autor:
Cas S. Dejonckheere, Alexander M. C. Böhner, Eva Schmitz, Tobias A. W. Holderried, Leonard C. Schmeel, Peter Brossart, Frank A. Giordano, Mümtaz A. Köksal
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7170-7174 (2023)
Abstract Total body irradiation (TBI) remains an important component in many conditioning regimens before allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Because of its frequent toxicity, patient selection is crucial, making it of i
Externí odkaz:
https://doaj.org/article/9ef65c7f4f084d8fa263d5417d2ccc24
Autor:
Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena Gaidzik, Michael Lauseker, Oliver Kriege, Mareike Verbeek, Julia Marie Unglaub, Felicitas Thol, Stefan W. Krause, Mathias Hänel, Charlotte Neuerburg, Vladan Vucinic, Christian-Friedrich Jehn, Julia Severmann, Maxi Wass, Lars Fransecky, Jens Chemnitz, Udo Holtick, Kerstin Schäfer-Eckart, Josephine Schröder, Sabrina Kraus, William Krüger, Ulrich Kaiser, Sebastian Scholl, Kathrin Koch, Lea Henning, Guido Kobbe, Rainer Haas, Nael Alakel, Maximilian-Alexander Röhnert, Katja Sockel, Maher Hanoun, Uwe Platzbecker, Tobias A. W. Holderried, Anke Morgner, Michael Heuser, Tim Sauer, Katharina S. Götze, Eva Wagner-Drouet, Konstanze Döhner, Hartmut Döhner, Christoph Schliemann, Johannes Schetelig, Martin Bornhäuser, Ulrich Germing, Thomas Schroeder, Jan Moritz Middeke
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 10, Pp 1-8 (2021)
Abstract To investigate the efficacy and toxicities of CPX-351 outside a clinical trial, we analyzed 188 patients (median age 65 years, range 26–80) treated for therapy-related acute myeloid leukemia (t-AML, 29%) or AML with myelodysplasia-related
Externí odkaz:
https://doaj.org/article/227f98dd88a74dfd8f202c1342f289b3
Autor:
Philipp A. Lang, Sarah Q. Crome, Haifeng C. Xu, Karl S. Lang, Laurence Chapatte, Elissa K. Deenick, Melanie Grusdat, Aleksandra A. Pandyra, Vitaly I. Pozdeev, Ruifeng Wang, Tobias A. W. Holderried, Harvey Cantor, Andreas Diefenbach, Alisha R. Elford, David R. McIlwain, Mike Recher, Dieter Häussinger, Tak W. Mak, Pamela S. Ohashi
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Elucidating key factors that regulate immune-mediated pathology in vivo is critical for developing improved strategies to treat autoimmune disease and cancer. NK cells can exhibit regulatory functions against CD8+ T cells following viral infection. H
Externí odkaz:
https://doaj.org/article/c6d755c74d6340298648772ef2029098
Autor:
Sebastian Schlaweck, Claus Juergen Bauer, Friederike Schmitz, Peter Brossart, Tobias A. W. Holderried, Valentin Sebastian Schäfer
Publikováno v:
Applied Sciences, Vol 12, Iss 2, p 829 (2022)
Sinusoidal obstruction syndrome (SOS) is a rare complication after allogeneic hematopoietic stem cell transplantation (alloHSCT) caused by endothelial dysfunction. Previous definitions and diagnostic criteria for the presence of SOS include bilirubin
Externí odkaz:
https://doaj.org/article/b08dfb56d3e24a848ddfc69d1873a17a
Autor:
Hartmut Goldschmidt, Elias K Mai, Uta Bertsch, Roland Fenk, Eva Nievergall, Diana Tichy, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M Asemissen, Bernhard Heilmeier, Niels Weinhold, Stefanie Huhn, Katharina Kriegsmann, Steffen P Luntz, Tobias A W Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Müller, Cyrus Khandanpour, Wolfgang Knauf, Christof Scheid, Markus Munder, Thomas Geer, Hendrik Riesenberg, Jörg Thomalla, Martin Hoffmann, Marc S Raab, Hans J Salwender, Katja C Weisel, Joachim Behringer, Helga Bernhard, Christiane Bernhardt, Igor W Blau, Claus Bolling, Daniel Debatin, Gerrit Dingeldein, Barbara Ferstl, Claudia Fest, Stefan Fronhoffs, Stephan Fuhrmann, Tobias Gaska, Martin Görner, Ullrich Graeven, Jochen Grassinger, Michael Heinsch, Gerhard Held, Olaf Hopfer, Peter Immenschuh, Dominic Kaddu-Mulindwa, Martine Klausmann, Stefan Klein, Yon-Dschun Ko, Georg Köchling, Michael Koenigsmann, Philippe Kostrewa, Doris Maria Kraemer, Stephan Kremers, Martin Kropff, Paul La Rosée, Rolf Mahlberg, Uwe Martens, Michael Neise, Holger Nückel, Wolfram Pönisch, Maria Procaccianti, Mohammed R Rafiyan, Peter Reimer, Armin Riecke, Mathias Rummel, Volker Runde, Markus Schaich, Christoph Scheid, Martin Schmidt-Hieber, Stefan Schmitt, Daniel Schöndube, Andreas Schwarzer, Peter Staib, Heike Steiniger, Dirk Sturmberg, Hans-Joachim Tischler, Arne Trummer, Barbara Tschechne, Walter Verbeek, Bettina Whitlock, Maike de Wit, Matthias Zaiß, Carsten Ziske
Publikováno v:
The Lancet Haematology. 9:e810-e821
Anti-CD38 monoclonal antibodies have consistently shown increased efficacy when added to standard of care for patients with multiple myeloma. We aimed to assess the efficacy of isatuximab in addition to lenalidomide, bortezomib, and dexamethasone in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa4e06ca167ce956ab3c750cb5371c4d
https://doi.org/10.1016/s2352-3026(22)00263-0
https://doi.org/10.1016/s2352-3026(22)00263-0
Autor:
Cas S. Dejonckheere, Alexander M. C. Böhner, Eva Schmitz, Tobias A. W. Holderried, Leonard C. Schmeel, Peter Brossart, Frank A. Giordano, Mümtaz A. Köksal
Publikováno v:
Cancer medicineREFERENCES.
Total body irradiation (TBI) remains an important component in many conditioning regimens before allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because of its frequent toxicity, patient selection is crucial, making it of interest to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e55200d4778505ca87e75b1922080d9c
https://pubmed.ncbi.nlm.nih.gov/36404470
https://pubmed.ncbi.nlm.nih.gov/36404470
Autor:
Paul G. Higgins, Tobias A. W. Holderried, Barbara Sifft, Christoph Scheid, F Goeser, Peter Brossart, Marta Rebeca Cruz Aguilar, Maria J G T Vehreschild, Fedja Farowski, Dominik Wolf, Christian P. Strassburg, Christoph K. Stein-Thoeringer
Publikováno v:
European Journal of Haematology. 107:229-245
RATIONALE Steroid refractory graft-vs-host disease (sr-GvHD) represents a challenging complication after allogeneic hematopoietic cell transplantation (allo-HCT). Intestinal microbiota (IM) diversity and dysbiosis were identified as influencing facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecd73503c9ea3d5fb63aba5c814c04bf
https://doi.org/10.1111/ejh.13642
https://doi.org/10.1111/ejh.13642
Autor:
Tim H. Brümmendorf, Stefan Wilop, Gerda Silling, Martina Wessiepe, Judith Gecht, Hatice Soysal, Martina Crysandt, Edgar Jost, Eva Jennes, Tobias A. W. Holderried, Udo Holtick, Matthias Mrotzek, Fabian Beier, Susanne Rehnelt, Uta Kunter
Publikováno v:
European Journal of Haematology. 107:324-332
OBJECTIVE ABO mismatch between donor and recipient occurs in 40% of allogeneic hematopoietic stem cell transplantations (HCT). Different strategies have been described to reduce isohemagglutinins (IHA) before HCT. We describe the effect of selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c634b36edb28dd6527e720a00f3b1d7
https://doi.org/10.1111/ejh.13668
https://doi.org/10.1111/ejh.13668